Tempus AI · 1 week ago
Data Scientist II, Translational Research
Tempus AI is dedicated to advancing precision medicine in the healthcare industry through its innovative data platform. The Data Scientist II role focuses on bridging the gap between analytical capabilities and client research needs, ensuring clients can effectively utilize Tempus' data for scientific inquiries.
Artificial Intelligence (AI)BiotechnologyHealth CareMachine LearningMedicalPrecision Medicine
Responsibilities
Lead the technical and scientific onboarding process for new clients, ensuring a smooth transition onto the Tempus Data Ecosystem and analytical platform
Engage with clients (primarily researchers and scientists) to deeply understand their specific scientific hypotheses and questions (e.g., biomarker discovery, target identification, clinical trial design)
Translate client scientific needs into actionable steps on the Tempus analytical platform. This includes designing workflows, structuring queries, and guiding the analysis of complex datasets (genomic, clinical, imaging)
Identify and implement technological solutions and workflow improvements to make the client experience on the platform as easy, efficient, and intuitive as possible
Act as the voice of the client, collaborating closely with Tempus Product, Engineering, and Data Science teams to prioritize features and resolve technical challenges
Create high-quality technical documentation, tutorials, and training materials for clients on platform features and best practices for scientific analysis
Qualification
Required
Advanced Scientific Degree: A Master's or Ph.D. in a relevant scientific field (e.g., Computational Biology, Bioinformatics, Genomics, Data Science, or a related life science discipline)
Data Analysis Proficiency: Demonstrated experience working with and analyzing large-scale biomedical datasets (e.g., Next-Generation Sequencing data, clinical trial data, real-world data)
Technical Fluency: Hands-on experience with analytical tools and languages relevant to biomedical research. Having R coding experience is required. Knowing additional languages such Python and SQL and familiarity with cloud environments like AWS/GCP is a great added bonus
Team work: Proven ability to work collaboratively in a team environment and thrive in a fast-paced environment, willing to shift priorities seamlessly
Client-Facing Experience: Excellent written and verbal communication skills with a proven ability to explain complex technical and scientific concepts to both technical and non-technical audiences
Problem-Solving Mindset: A strong track record of identifying inefficiencies or scientific roadblocks and developing pragmatic, user-friendly solutions
Preferred
Experience in the biotech, pharma, or healthcare technology space
Familiarity with distributed computing environments and modern analytical platforms
Direct experience with oncology research
Experience with R package development
Experience with: Pandas, NumPy, SciPy, Scikit-learn, Jupyter Notebooks, RStudio, R Package development, tidyverse, ggplot, Git, matplotlib, seaborn, HTML5, CSS3, JavaScript, D3, Plot.ly, Flask, Dask, Docker, AWS
Benefits
Tempus offers a full range of benefits, which may include incentive compensation, restricted stock units, medical and other benefits depending on the position.
Company
Tempus AI
Tempus is making precision medicine a reality by applying AI in healthcare, deriving insights from our expansive library of clinical data and molecular data.
H1B Sponsorship
Tempus AI has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2021 (3)
Funding
Current Stage
Public CompanyTotal Funding
$2.29BKey Investors
Ares ManagementGoogleBaillie Gifford
2025-06-30Post Ipo Debt· $650M
2025-02-19Post Ipo Debt· $300M
2024-06-14IPO
Recent News
2026-01-06
Company data provided by crunchbase